Robert Anthenelli

Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers

National Institute on Drug Abuse · U01

PI · $3.1M · Sanford Burnham Prebys Medical Discovery Institute

Clinical Development of an mGlu2 Positive Allosteric Modulator to Treat Nicotine Addiction

National Institute on Drug Abuse · U01

PI · $11.4M · Sanford Burnham Prebys Medical Discovery Institute

Exploring Potential Sex Differences In Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance

National Institute on Alcohol Abuse and Alcoholism · R33

Contact PI · $2.1M · University of California, San Diego

Exploring Potential Sex Differences In Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance

National Institute on Alcohol Abuse and Alcoholism · R21

Contact PI · $407.2K · University of California, San Diego

New Treatment for Alcohol and Nicotine Dependence

Principal investigator · Completed · Phase 2, Phase 3

University of Virginia

Topiramate to Aid Smoking Cessation in Alcohol Dependent Men

Principal investigator · Completed · Phase 2

VA Office of Research and Development

Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)

Principal investigator · Completed · Phase 2

University of Cincinnati

Alcohol and Gender Effects on Stress Circuit Function

Principal investigator · Completed

University of Cincinnati